SK Biopharmaceuticals Wins Red Dot Design Award for Wearable Devices

SK Biopharmaceuticals, an innovative global pharmaceuticals company, announced that its digital wearable devices – Zero WiredTM and Zero EarbudsTM – have won the Red Dot Design Award 2023 in the healthcare category for outstanding design.

The Red Dot Design Award is one of the world’s top design competitions that recognizes products for their design, aesthetics, functionality, impact, and innovation.

Zero WiredTM, a wired device connectable to mobile phones, and Zero EarbudsTM, an earbud device adjustable to fit various head sizes, measure bio-signals from brain activity, heart rhythm, and body movement.

SK Biopharmaceuticals is developing five wearable devices under the so-called “Project ZeroTM,”[1] aimed at optimizing its digital healthcare business model and ecosystem. The project’s name is derived from the company’s key mission to strive for the potential of “zero seizures” for patients with epilepsy.

Winning the Red Dot Design Award is the second global accolade achieved by the company for its wearable devices. Zero WiredTM and Zero GlassesTM earned the CES® 2023 Innovation Awards for outstanding design and engineering from the Consumer Technology Association, the host of the world’s biggest tech exhibition CES, in November, 2022.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version